Cargando…
Borreliacidal activity of Borrelia metal transporter A (BmtA) binding small molecules by manganese transport inhibition
Borrelia burgdorferi, the causative agent of Lyme disease, utilizes manganese (Mn) for its various metabolic needs. We hypothesized that blocking Mn transporter could be a possible approach to inhibit metabolic activity of this pathogen and eliminate the infection. We used a combination of in silico...
Autores principales: | Wagh, Dhananjay, Pothineni, Venkata Raveendra, Inayathullah, Mohammed, Liu, Song, Kim, Kwang-Min, Rajadas, Jayakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330029/ https://www.ncbi.nlm.nih.gov/pubmed/25709405 http://dx.doi.org/10.2147/DDDT.S77063 |
Ejemplares similares
-
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2016) -
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2020) -
In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2018) -
Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against Borrelia burgdorferi In Vitro and In Vivo
por: Potula, Hari-Hara S. K., et al.
Publicado: (2020) -
Effect of osmolytes on the conformation and aggregation of some amyloid peptides: CD spectroscopic data
por: Inayathullah, Mohammed, et al.
Publicado: (2016)